This course familiarizes users with designer drugs, known as “legal highs,” summarizes common effects of these drugs, and provides treatment recommendations.
a). Discuss the epidemiology of emerging designer drugs.
b). Name at least one designer drug in each of the drug classes: stimulants, cannabinoids, and hallucinogens.
c). Describe both common clinical and psychiatric effects of designer drugs.
d). Identify at least five indicators of designer drug use.
e). Discuss two treatment recommendations for clients suffering from designer drug use.
The target audience for this event includes psychologists, licensed clinical social workers, licensed counselors, MFT’s, and other clinical mental health professionals.
Instructor(s): Jennifer Sweeton, Psy.D, MS, MA
Material Author(s): Michael F. Weaver, John A. Hopper, & Erik W. Gunderson
For additional information about this course, the instructors, or the material authors, please contact Content Assistance at [email protected]